Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of the Chinese Prescription Weiqi Decoction on Chronic Atrophic Gastritis

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2009 by Shanghai University of Traditional Chinese Medicine.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Shanghai University of Traditional Chinese Medicine
ClinicalTrials.gov Identifier:
NCT00920712
First received: June 11, 2009
Last updated: August 20, 2009
Last verified: August 2009

June 11, 2009
August 20, 2009
August 2009
June 2011   (final data collection date for primary outcome measure)
Symptoms and conditions of tongue and pulse,the gastroscopy and pathological change [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00920712 on ClinicalTrials.gov Archive Site
Indicates of liver and renal function [ Time Frame: 12 weeks ] [ Designated as safety issue: Yes ]
Same as current
Not Provided
Not Provided
 
Study of the Chinese Prescription Weiqi Decoction on Chronic Atrophic Gastritis
Not Provided

The purpose of this study is to evaluate the efficacy and safety of the Chinese prescription Weiqi decoction on Chronic Atrophic Gastritis.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Outcomes Assessor)
Primary Purpose: Treatment
Gastritis
Drug: Weiqi decotion
Decoction ,two times a day
  • Experimental: Weiqi decoction
    Intervention: Drug: Weiqi decotion
  • Placebo Comparator: low dose of Weiqi decoction
    Intervention: Drug: Weiqi decotion
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
200
July 2011
June 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Clinical diagnosis of Chronic Atrophic Gastritis
  • Male of female patients between 18-65 years old
  • Written informed consent

Exclusion Criteria:

  • Combine with malignant pathology on epithelial dysplasia of gastric mucosa
  • Combine with duodenal ulcer or gastric ulcer
  • Combined with severe heart, gallbladder, kidney, endocrine system, hemopoietic system or nervous system disease.
  • Pregnancy or breast feeding women, or unwilling to have contraception.
Both
18 Years to 65 Years
No
China
 
NCT00920712
SHTCM-001
Yes
Institute of Spleen and Stomach's diseases, Shanghai University of Traditional Chinese Medicine
Shanghai University of Traditional Chinese Medicine
Not Provided
Study Director: Xie Jianqun, Phd Shanghai University of Chinese Medicine
Shanghai University of Traditional Chinese Medicine
August 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP